GlassScriptPhysician profile
Michelle Melanson
NPI 1396108528
$1,570.40
in general payments reported to CMS, 2019-2025
19 companies · $338 in 2025
The $338 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $62.80 · 2021: $337 · 2022: $355 · 2023: $363 · 2024: $114 · 2025: $338.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $815.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $815.09 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $263.36 | 2020-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $186.47 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $169.95 | 2023-2025 | Myfembree |
| Astellas Pharma US INC | $143.50 | 2025 | Veozah |
| Therapeuticsmd, INC. | $133.65 | 2020-2022 | |
| Mayne Pharma Commercial LLC | $133.52 | 2021-2025 | |
| Pfizer INC. | $109.67 | 2021-2025 | |
| Organon LLC | $96.33 | 2022-2025 | Jada System |
| Evofem Biosciences, INC. | $82.52 | 2021-2022 | |
| Scynexis, INC. | $45.02 | 2022 | |
| Coopersurgical, INC. | $33.42 | 2022-2024 | Paragard T 380a |
| Heron Therapeutics, INC. | $30.13 | 2023 | Zynrelef |
| Exact Sciences Corporation | $30.02 | 2023-2024 | Cologuard Collection Kit |
| Merck Sharp & Dohme LLC | $28.99 | 2021-2023 | Gardasil 9 |
| Gilead Sciences, INC. | $21.96 | 2025 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hologic Sales and Service, LLC | $16.16 | 2021 | |
| Myovant Sciences INC. | $15.86 | 2022 | |
| Exeltis, USA INC. | $15.79 | 2022 | |
| Agile Therapeutics, INC. | $14.08 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Melanson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.